Sylvain Baize researcher
Baize, Sylvain
VIAF ID: 203331463 (Personal)
Permalink: http://viaf.org/viaf/203331463
Preferred Forms
- 100 1 _ ‡a Baize, Sylvain
- 100 0 _ ‡a Sylvain Baize ‡c researcher
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
A 40-Month Follow-Up of Ebola Virus Disease Survivors in Guinea (PostEbogui) Reveals Long-Term Detection of Ebola Viral Ribonucleic Acid in Semen and Breast Milk | |
Arenaviridae exoribonuclease presents genomic RNA edition capacity | |
Comparative analysis of pathogenic and protective mechanisms occurring during the course of Lassa fever in cynomolgus monkeys. | |
Défis du diagnostic des infections virales en zones de conflits : fièvres d'origine inexpliquée et arboviroses dans les forces françaises déployées en Afrique | |
Développement de nouvelles approches thérapeutiques dans la lutte contre les infections à arénavius : vaccination et immunothérapie passive | |
Dynamics of Ebola RNA Persistence in Semen: A Report From the Postebogui Cohort in Guinea | |
E3 Ligase ITCH Interacts with the Z Matrix Protein of Lassa and Mopeia Viruses and Is Required for the Release of Infectious Particles | |
Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys | |
Early control of viral load by favipiravir promotes survival to Ebola virus challenge and prevents cytokine storm in non-human primates | |
Early immune responses accompanying human asymptomatic Ebola infections | |
Ebola and Marburg hemorrhagic fever viruses: update on filoviruses | |
Ebola hemorrhagic fever: a unique efficacious vaccine dose in primates | |
Ebola: should we consider influenza vaccination? | |
Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies | |
Ebola virus in West Africa: new conquered territories and new risks-or how I learned to stop worrying and (not) love Ebola virus | |
Efficacy of Convalescent Plasma in Relation to Dose of Ebola Virus Antibodies | |
Epidemics of Ebola haemorrhagic fever in Gabon (1994-2002). Epidemiologic aspects and considerations on control measures | |
Etude comparative de l'interactome des nucléoprotéines, polymérases et protéines de matrice des virus Lassa et Mopeia | |
Etude in vitro des réponses lymphocytaires T humaines induites par les virus Lassa et Mopeia | |
Evidence for Ebola virus superantigen activity | |
The exonuclease domain of Lassa virus nucleoprotein is involved in antigen-presenting-cell-mediated NK cell responses | |
Experimental infection of a nonhuman primate with Loa loa induces transient strong immune activation followed by peripheral unresponsiveness of helper T cells. | |
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea | |
Fatal Case of Lassa Fever, Bangolo District, Côte d'Ivoire, 2015 | |
Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted | |
Flavivirus serological discrimination, study of the Zika virus envelope protein domain III as a target for specific antibodies.. | |
Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis | |
Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014. | |
Immune parameters and outcomes during Ebola virus disease | |
Inflammatory responses in Ebola virus-infected patients. | |
Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs | |
Investigation into the pathogenesis of Bolivian hemorrhagic fever in cynomolgus monkeys. | |
Isolation and partial molecular characterisation of a strain of Ebola virus during a recent epidemic of viral haemorrhagic fever in Gabon | |
[Lassa virus and myeloid dendritic cells: a privileged tropism for the suppression of the T lymphocyte response] | |
Mécanisme de transmission de signal viral immunostimulateur des cellules infectés aux cellules dendritiques plasmacytoïdes par contacts cellulaires. | |
Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study | |
Natural Killer cells and hemorrhagic fevers : study of their role in the induction of the immune responses and the pathogenesis during the infection by Lassa and Ebola viruses. | |
New Evidence of Long-lasting Persistence of Ebola Virus Genetic Material in Semen of Survivors | |
NK cells are strongly activated by Lassa and Mopeia virus-infected human macrophages in vitro but do not mediate virus suppression | |
Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014. | |
Non-Pathogenic Mopeia Virus Induces More Robust Activation of Plasmacytoid Dendritic Cells than Lassa Virus | |
Pathologie comparée de la fièvre de Lassa chez le singe cynomolgus : mécanismes pathogéniques précoces, réponses immunitaires et marqueurs d'infection | |
Poly(I)-Poly(C12U) but Not Ribavirin Prevents Death in a Hamster Model of Nipah Virus Infection | |
Production of CXC and CC chemokines by human antigen-presenting cells in response to Lassa virus or closely related immunogenic viruses, and in cynomolgus monkeys with lassa fever | |
La réponse immune au cours de l'infection humaine par le virus Ebola | |
The role of a cryptic furin-like cleavage site on Ebola virus replication | |
Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages. | |
Sequence analysis of the GP, NP, VP40 and VP24 genes of Ebola virus isolated from deceased, surviving and asymptomatically infected individuals during the 1996 outbreak in Gabon: comparative studies and phylogenetic characterization | |
Severe Ebola Virus Infection With Encephalopathy: Evidence for Direct Virus Involvement. | |
A single shot against Ebola and Marburg virus | |
Strengthened Ebola surveillance in France during a major outbreak in West Africa: March 2014-January 2016. | |
Systemic viral spreading and defective host responses are associated with fatal Lassa fever in macaques | |
T helper responsiveness in human Loa loa infection; defective specific proliferation and cytokine production by CD4+ T cells from microfilaraemic subjects compared with amicrofilaraemics | |
Towards broad protection against Ebolaviruses | |
Towards deep insight into Ebola virus disease | |
A vaccine platform against arenaviruses based on a recombinant hyper-attenuated Mopeia virus expressing heterologous glycoproteins. | |
Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot | |
Viral zoonoses and emergence: research is just starting | |
ヒトの無症候性エボラ感染と強い炎症反応 |